Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LLAP
1851
DELISTED
Terran Orbital Corporation
LLAP
| $11.6M | 0.01% |
1,188,600
+890,101
| +298% | +$8.64M |
|
1852
CALL
Vistra
VST
$47B
| $11.5M | 0.01% |
675,000
+175,000
| +35% | +$3.23M |
|
|
DCPH
1853
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $11.5M | 0.01% |
339,311
+129,546
| +62% | +$4.13M |
|
|
EQD
1854
DELISTED
Equity Distribution Acquisition Corp.
EQD
| $11.5M | 0.01% |
1,172,746
+57,500
| +5% | +$563K |
|
|
VTNR
1855
DELISTED
Vertex Energy, Inc
VTNR
| $11.5M | 0.01% |
2,196,577
+1,884,369
| +604% | +$15M |
|
1856
CNO Financial Group
CNO
$5.06B
| $11.5M | 0.01% |
488,819
-59,292
| -11% | -$1.39M |
|
|
IPVF
1857
DELISTED
InterPrivate III Financial Partners Inc.
IPVF
| $11.5M | 0.01% |
1,160,651
+856,448
| +282% | +$8.4M |
|
|
HES
1858
PUT
DELISTED
Hess
HES
| $11.5M | 0.01% |
147,100
+61,400
| +72% | +$4.52M |
|
|
MTOR
1859
DELISTED
MERITOR, Inc.
MTOR
| $11.5M | 0.01% |
538,871
+217,262
| +68% | +$5.06M |
|
1860
Grocery Outlet
GO
$1.21B
| $11.5M | 0.01% |
+531,706
| New | +$15.3M |
|
|
NEWR
1861
DELISTED
New Relic, Inc.
NEWR
| $11.5M | 0.01% |
159,754
+150,527
| +1,631% | +$11.1M |
|
|
DEA
1862
Easterly Government Properties
DEA
$1.17B
| $11.5M | 0.01% |
+221,955
| New | +$12M |
|
1863
Heartland Express
HTLD
$964M
| $11.4M | 0.01% |
714,600
-38,181
| -5% | -$637K |
|
1864
Dine Brands
DIN
$446M
| $11.4M | 0.01% |
140,744
+54,873
| +64% | +$4.41M |
|
|
ALTA
1865
DELISTED
Altabancorp
ALTA
| $11.4M | 0.01% |
258,744
+244,510
| +1,718% | +$10.1M |
|
1866
NETSCOUT
NTCT
$2.8B
| $11.4M | 0.01% |
423,636
+271,855
| +179% | +$7.54M |
|
|
TTM
1867
DELISTED
Tata Motors Limited
TTM
| $11.4M | 0.01% |
508,941
-154,322
| -23% | -$3.14M |
|
|
ZGNX
1868
DELISTED
Zogenix, Inc.
ZGNX
| $11.4M | 0.01% |
750,329
-308,307
| -29% | -$4.82M |
|
1869
CVS Health
CVS
$121B
| $11.4M | 0.01% |
134,251
+28,014
| +26% | +$2.35M |
|
1870
PUT
Colgate-Palmolive
CL
$73.4B
| $11.4M | 0.01% |
150,700
+4,600
| +3% | +$365K |
|
1871
BCE
BCE
$21.9B
| $11.4M | 0.01% |
226,890
+130,771
| +136% | +$6.62M |
|
1872
Acuity Brands
AYI
$10.2B
| $11.3M | 0.01% |
65,448
+53,823
| +463% | +$9.43M |
|
1873
Safe Bulkers
SB
$843M
| $11.3M | 0.01% |
2,192,570
-180,959
| -8% | -$698K |
|
|
REVG
1874
DELISTED
REV Group
REVG
| $11.3M | 0.01% |
658,357
+431,284
| +190% | +$6.87M |
|
|
PRPC
1875
DELISTED
CC Neuberger Principal Holdings III
PRPC
| $11.3M | 0.01% |
1,155,857
-87,603
| -7% | -$853K |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.